Where is Glysantis located?

Glysantis is headquartered in Guelph, Canada.

How many employees does Glysantis have?

As of May 31, 2026, the latest employee count at Glysantis is 3.

Is Glysantis a funded company?

Glysantis is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Glysantis rank among its competitors?

Glysantis ranks 1393rd amongst 2203 active competitors, of which 526 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Glysantis?

Glysantis' top competitors include Synthego, Liquidia and Antheia. Among them, Antheia secured the most recent funding round in January, 2026.

Glysantis - 2026 Company Profile & Competitors

Company Details

Glysantis is a biomedical company active in preclinical research and development of novel nano-medicines. The company has developed a proprietary NanoGlysplatform technology which involves phytoglycogen extracted from plants, the nano-sized particle can be used for therapies with a wide range of clinical indications. These monodisperse carbohydrate nano-particles are at the core of technology and can be easily modified to be novel active ingredients for targeted drug delivery.

Website: glysantis.com
Part Of

Key Metrics

Founded Year

2015

Location

Guelph, Canada

Stage

Unfunded

Ranked

1393^rd among 2203 active competitors

Employee Count

3 as on May 31, 2026

Similar Companies

Synthego & 2986 more

View Glysantis' full profile

Glysantis has not raised any funding rounds yet.

Glysantis' employee count trend

Glysantis has 3 employees as of May 26. Here is Glysantis's employee count trend over the years:

Uncover Glysantis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Glysantis include Synthego, Liquidia and Antheia. Here is the list of Top 10 competitors of Glysantis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, Perceptive Advisors & 30 others	59/100
2nd	Liquidia 2004, Morrisville (United States), Public	Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions	$90.3M	Morningside, Gates & 18 others	67/100
3rd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
4th	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Sequoia Capital & 11 others	66/100
5th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
6th	Vaxxas 2010, Brisbane (Australia), Series D	Developer of a needle-free patch technology for vaccine delivery applications	$91.2M	One Ventures, UniQuest & 12 others	65/100
7th	Genedit 2016, Berkeley (United States), Series B	Developer of drug delivery system for genetic medicines	$93.5M	IMM Investment, SK & 20 others	65/100
8th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Fidelity Investments ... & 14 others	64/100
9th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Bpifrance & 14 others	63/100
10th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	UBS, Brown Brothers Harriman & 1 others	63/100
1393rd	Glysantis 2015, Guelph (Canada), Unfunded	Develops a biomaterial for use in therapeutics	-	-	24/100